PHARMING AND SANTARUS ANNOUNCE NEW DATA FROM OPEN-LABEL REPEAT TREATMENT STUDY WITH RUCONEST (RECOMBINANT HUMAN C1 ESTERASE INHIBITOR)
08 nov. 2013 01h06 HE
|
Pharming Group N.V.
LEIDEN, Netherlands and SAN DIEGO, Nov. 8, 2013 (GLOBE NEWSWIRE) --
Pharming Group NV (NYSE
Euronext: PHARM) and Santarus, Inc. (NASDAQ: SNTS) announced that new data from
an open-label extension of...
Pharming Reports On Financial Results For The First Nine Months Of 2013
07 nov. 2013 01h10 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 7, 2013 (GLOBE NEWSWIRE) --
Biotech company Pharming Group NV
("Pharming" or "the Company") (NYSE Euronext: PHARM) today published its
financial report for the first nine...
Pharming announces EU12.0 million private equity placement with institutional investors
09 oct. 2013 01h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 9, 2013 (GLOBE NEWSWIRE) --
Biotech company Pharming Group NV
("Pharming" or "the Company") (NYSE Euronext: PHARM) today announced that it has
entered into a private...
Pharming's Marketing Authorization Application for Rhucin -- RHC1INH -- Accepted for Review by EMEA
17 août 2006 12h58 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Aug. 17, 2006 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming") (Euronext:PHARM) (PHARM.AS) announced today that its Marketing Authorization Application (MAA) for...
Pharming Presents rhC1INH Update at International Meetings
17 nov. 2005 02h13 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 17, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that the Company presented clinical...
Pharming Candidate for Amsterdam Midkap Index on Euronext
09 nov. 2005 02h18 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 09, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has been selected by Euronext...
Pharming Announces Results for First Nine Months 2005
03 nov. 2005 01h24 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Nov. 3, 2005 (PRIMEZONE) -- Highlights: upcoming product filings, licensing progress and pipeline expansion. Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM)...
Pharming Appoints New Head of Finance and Administration
24 oct. 2005 01h09 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 24, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today that it has appointed Mr. Wim J. E....
Pharming Presents Human Lactoferrin Results at International Conference
19 oct. 2005 08h07 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Oct. 19, 2005 (PRIMEZONE) -- Biotech company Pharming Group N.V. ("Pharming" or "the Company") (Euronext: PHARM) (PHARM.AS) announced today results from three studies which...
Pharming Expands Clinical Development of Recombinant Human C1 Inhibitor for new Indications
29 sept. 2005 01h12 HE
|
Pharming Group N.V.
LEIDEN, Netherlands, Sept. 29, 2005 (PRIMEZONE) -- Biotech companyPharming Group N.V. ("Pharming" or "the Company") (Euronext:PHARM) (PHARM.AS) announced today that it will commence clinical...